Summary
patients treated
Has anyone ever benefited from stem cell?
For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.
FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.
List of patients
| No. | Source | Source type | Diagnosis | Medical sector | Year of application | Therapy | Country | Age of the recipient |
|---|---|---|---|---|---|---|---|---|
| 4601 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 19 |
| 4602 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 68 |
| 4603 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 62 |
| 4604 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 67 |
| 4605 | Apheresis | Allogeneic | Acute Myeloid Leukemia; Myeloproliferative Syndrome | Hematology | 2018 | Standard Therapy | Germany | 62 |
| 4606 | Apheresis | Autologous | Amyloidosis | Hematology | 2018 | Standard Therapy | Germany | 72 |
| 4607 | Apheresis | Autologous | Amyloidosis | Hematology | 2018 | Standard Therapy | Germany | 75 |
| 4608 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2018 | Standard Therapy | Germany | 61 |
| 4609 | Apheresis | Autologous | Apoplexy | Hematology | 2018 | Standard Therapy | Germany | 3 |
| 4610 | Apheresis | Allogeneic | Atypical Chronic Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 58 |
| 4611 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 41 |
| 4612 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 50 |
| 4613 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 34 |
| 4614 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 34 |
| 4615 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 52 |
| 4616 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 46 |
| 4617 | Apheresis | Allogeneic | B-Cell Chronic Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 65 |
| 4618 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 69 |
| 4619 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 43 |
| 4620 | Apheresis | Allogeneic | B-Cell Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 66 |
| 4621 | Apheresis | Allogeneic | B-Cell Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 32 |
| 4622 | Apheresis | Allogeneic | Blastic Nk Cell Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 65 |
| 4623 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2018 | Standard Therapy | Poland | 15 |
| 4624 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2018 | Standard Therapy | Poland | 2 |
| 4625 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 49 |
| 4626 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 38 |
| 4627 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2018 | Standard Therapy | Poland | 63 |
| 4628 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2018 | Standard Therapy | Poland | 48 |
| 4629 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2018 | Standard Therapy | Poland | 25 |
| 4630 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2018 | Standard Therapy | Poland | 41 |
| 4631 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2018 | Standard Therapy | Germany | 44 |
| 4632 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2018 | Standard Therapy | Germany | 54 |
| 4633 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 39 |
| 4634 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 63 |
| 4635 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 56 |
| 4636 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 71 |
| 4637 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 51 |
| 4638 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 67 |
| 4639 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 67 |
| 4640 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 49 |
| 4641 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 60 |
| 4642 | Apheresis | Allogeneic | Diffuse Large B-Cell Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 54 |
| 4643 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 71 |
| 4644 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma – Relapse | Hematology | 2018 | Standard Therapy | Germany | 71 |
| 4645 | Apheresis | Allogeneic | Fanconi Anemia | Hematology | 2018 | Standard Therapy | Poland | 9 |
| 4646 | Apheresis | Allogeneic | Follicular Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 44 |
| 4647 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 65 |
| 4648 | Apheresis | Allogeneic | Follicular Lymphoma (Non-Hodgkin Lymphoma) | Hematology | 2018 | Standard Therapy | Poland | 56 |
| 4649 | Apheresis | Autologous | Germ Cell Tumor | Hematology | 2018 | Standard Therapy | Germany | 23 |
| 4650 | Apheresis | Autologous | Germ Cell Tumor | Hematology | 2018 | Standard Therapy | Germany | 31 |
| 4651 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 38 |
| 4652 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 27 |
| 4653 | Apheresis | Allogeneic | Hypoplastic Mds-Eb2 With Incipient Saml | Hematology | 2018 | Standard Therapy | Poland | 63 |
| 4654 | Apheresis | Autologous | Large B-Cell Non-Hodgkin-Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 66 |
| 4655 | Apheresis | Allogeneic | Leukemia | Hematology | 2018 | Standard Therapy | Poland | 34 |
| 4656 | Apheresis | Allogeneic | Lymphomatoid Granulomatosis | Hematology | 2018 | Standard Therapy | Germany | 36 |
| 4657 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 66 |
| 4658 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 64 |
| 4659 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 44 |
| 4660 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 66 |
| 4661 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2018 | Standard Therapy | Germany | 65 |
| 4662 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2018 | Standard Therapy | Germany | 31 |
| 4663 | Apheresis | Allogeneic | Morbus Hodgkin-Relapse | Hematology | 2018 | Standard Therapy | Germany | 35 |
| 4664 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 67 |
| 4665 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 61 |
| 4666 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 61 |
| 4667 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 66 |
| 4668 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 57 |
| 4669 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 53 |
| 4670 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 57 |
| 4671 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 65 |
| 4672 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 47 |
| 4673 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 60 |
| 4674 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 66 |
| 4675 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 62 |
| 4676 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 67 |
| 4677 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 65 |
| 4678 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 54 |
| 4679 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 58 |
| 4680 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 51 |
| 4681 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 69 |
| 4682 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 52 |
| 4683 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 62 |
| 4684 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 62 |
| 4685 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 65 |
| 4686 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 62 |
| 4687 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 64 |
| 4688 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 63 |
| 4689 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 55 |
| 4690 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 60 |
| 4691 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 61 |
| 4692 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 62 |
| 4693 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 64 |
| 4694 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 55 |
| 4695 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 65 |
| 4696 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 64 |
| 4697 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 52 |
| 4698 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 61 |
| 4699 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 69 |
| 4700 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 73 |